Canaccord Tseeb tau nce tus nqi phiaj rau Selecta Biosciences Inc (Nasdaq: SELB) los ntawm $ 9 rau $ 10 thaum tswj hwm qhov Kev Ntsuam Xyuas Ua ntej ntawm cov ntaub ntawv yav tom ntej los ntawm ob theem 3 kev tshawb fawb ntawm SEL-212 rau cov mob chronic refractory gout.
Tus kws tshuaj ntsuam cia siab tias cov ntaub ntawv saum toj kawg nkaus zoo hauv 1Q23 rau SEL-212.
Txawm hais tias ntau tus yuav zoo li piv cov txiaj ntsig rau Horizon Therapeutics PLC's (NASDAQ: HZNP) Krystexxa thiab ntau yam immunomodulating ua ke, Canaccord pom SEL-212 ua ib kauj ruam ua ntej hauv kev kho gout paradigm. Kev kho mob ib zaug ib hlis ua rau nws sib nrug ntawm Krystexxa.
Tus kws tshuaj ntsuam xav tias yuav muaj 40-50% teb tus nqi ntawm rau lub hlis. SOBI tau coj BLA lus 2h23. Ob qhov kev tshawb fawb yuav ntsuas qhov kawg ntawm rau lub hlis, tab sis DISSOLVE II kuj suav nrog kev soj ntsuam ntxiv 6 lub hlis.
SEL-12 yav dhau los tau qhia txog 53% tus nqi teb vs.
Tsis ntev los no, Selecta Biosciences thiab Astellas Pharma Inc. (OTC: ALPMF(OTC): ALPMY) tshaj tawm tsab ntawv tso cai tshwj xeeb thiab kev cog lus tsim kho rau IdeXork (Xork) raws li qhov muaj peev xwm ua rau lwm tiam immunoglobulin G (IgG) protease.
Astellas yuav siv IgG nrog AT845, kev tshawb nrhiav noob kho rau tus kab mob Pompe.
Selecta yog kom tau txais $ 10 lab them ua ntej thiab tsim nyog tau txais txog $ 340 lab rau qee qhov kev txhim kho ntxiv thiab kev lag luam tseem ceeb, ntxiv rau royalties ntawm kev muag khoom.
Nqe Nqis: SELB shares tau nce 0.21% ntawm $ 1.76 ntawm daim tshev kawg hnub Tuesday.
Tseeb Ratings rau SELB
Hnub | Tshaj tawm | Action | Los ntawm | Yuav |
|---|---|---|---|---|
Nov 2021 | Needham | Txij nkawm | yuav | |
Jun 2021 | BTIG | Pib Kev Npam Ntawm | yuav | |
ti 2021 | William Blair | hloov khoom dua tshiab | Kev Ua Lag Luam | Txoj Kev Ua Txhaum |
Saib Ntau Cov Kev Ntsuas Ntsuas rau SELB
Saib Qhov Ntsuam Kev Ntsuam Xyuas Cov Ntaus Tawm Tshiab
Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.
Tshooj no Tus kws tshuaj ntsuam hais tias Selecta Biosciences 'Gout Candidate tuaj yeem tsa lub Bar ntawm ob peb Fronts Ameslikas nyob rau hauv benzinga.com
.
© 2023 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.
Tau qhov twg los: https://finance.yahoo.com/news/analyst-says-selecta-biosciences-gout-181548891.html